Sentences with phrase «known as a breast cancer»

October is also widely known as Breast Cancer Awareness Month, and this could be a great opportunity to showcase what you or your office are doing to help support this great cause.

Not exact matches

As a woman, I can not say enough about how important it is that we all know about breast cancer, how to detect it, and steps to take to support those with breast cancer.

Additionally, these little seeds pack a whole lot of lignans, a natural antioxidant known for helping to prevent certain types of cancer, such as breast and colon cancer.

As we all know, October is National Breast Cancer Awareness Month.

These fragrances can not only be irritating to a baby's respiratory system, but many of them have been known to cause things like disrupted hormone activity as well as liver and breast cancers.

Support a multi-year effort led by world - class scientists to develop a blood test for earlier detection of breast cancer when survival rates are the highest, known as the EIF Breast Cancer Biomarker Discovery Prbreast cancer when survival rates are the highest, known as the EIF Breast Cancer Biomarker Discovery Prcancer when survival rates are the highest, known as the EIF Breast Cancer Biomarker Discovery PrBreast Cancer Biomarker Discovery PrCancer Biomarker Discovery Project.

Camp Kesem is very near and dear to her heart because she aspires to be an oncologist and she fell in love as soon as she read about Camp Kesem's mission because her mom had breast cancer while she was growing up and knows how much she would have benefited if she had been able to go to a camp like Kesem.

So it reduces the risk of Breast Cancer again, you know, developing for as much as....

We don't know if pumping breast milk offers moms the same benefits of breastfeeding, such as increased postpartum weight loss, and reduced risk of postpartum depression, multiple reproductive cancers, rheumatoid arthritis, osteoporosis, Type 2 diabetes, heart disease, and high blood pressure.

• Breastmilk contains special antibodies which help protect your baby against infections • Breastmilk is your baby's natural food, it's easily digested and enough on its own for the first 6 months • Breastfed babies are less likely to have eczema and diabetes or high blood pressure and obesity later on • Breastfeeding helps you and your baby to get to know each other • Breastfeeding means you'll return to your pre-pregnancy weight quicker • Breastfeeding helps give you stronger bones in later life and helps protect against breast and ovarian cancer • Breastfed babies are not as windy as bottle - fed babies • Nappies are not as smelly!

One floor below Dr. Bett's office, Dr. Kate Rittenhouse Olson is leading a company known as For Robin, named in memory of her sister, who died several years ago from breast cancer.

UFT President Michael Mulgrew said, «As a union with a large female membership, we know the importance of the kind of health care that Planned Parenthood provides, including breast cancer screening.»

Among the changes in the American Cancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofCancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofcancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofcancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue of JAMA.

But it assesses only three of the more than 1,000 known BRCA1 / 2 mutations, raising concerns that women who are told they do not have any of those variants will be lulled into believing that, as a result, they do not have an elevated risk for breast and ovarian cancer.

Women with the KRAS - variant are also more susceptible to triple - negative breast cancer, tumors whose growth is not fueled by the hormones estrogen and progesterone, or by the presence of a particular genetic mutation known as HER2, which promotes cancer cell growth.

Breast cancers that metastasize to the brain are usually deadly, but a team based at the University of Mississippi Medical Center has discovered a possible fix: a tiny fragment of genetic material known as microRNA.

These «chance» cases are known as sporadic breast cancer.

«There are still many questions left to answer but we now know that oxygen poor environments, like those often found in advanced human breast cancers serve as nurseries for the birth of cancer stem cells,» says Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine and a member of the Johns Hopkins Kimmel Cancer Ccancer stem cells,» says Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine and a member of the Johns Hopkins Kimmel Cancer CCancer Center.

«We know that patients with BRCA mutations are at high risk for developing breast, as well as pancreatic, ovarian, prostate and other cancers, and we have learned over time that BRCA plays a very important role in DNA damage repair.

The groundbreaking study identified a protein, known as cadherin - 22, as a potential factor in cancer metastasis, or spread, and showed that hindering it decreased the adhesion and invasion rate of breast and brain cancer cells by up to 90 per cent.

Around 70 % of all cases of breast cancer are oestrogen - receptor positive, meaning that the cancer cells have a particular protein (known as a receptor) that responds to the female sex hormone oestrogen, enabling the tumour to grow.

BRCA1 and 2, genes whose proteins are supposed to work as tumor suppressors and also repair DNA damage, were the first known risk factor genes for familial breast cancer as well as ovarian and other cancers.

Now a team of researchers from Central South University in China have demonstrated that a technique known as photoacoustic imaging, which is already under investigation for detecting skin or breast cancers and for monitoring therapy, also has the potential to be a new, faster, cheaper and non-invasive method to detect, diagnose and stage cervical cancer with high accuracy.

The primary endpoint of this trial is recurrence of breast cancer in the same breast, known as ipsilateral breast tumor recurrence (IBTR).

By searching for gene deletion patterns in cancer through a concept the investigators call «synthetic essentiality,» the team identified a synthetic essential gene known as chromatin helicase DNA - binding factor (CHD1) as a therapeutic target for prostate and breast cancers lacking a tumor suppressor gene called phosphatase and tensin homolog (PTEN).

«Forty years ago, very little was known about breast cancer disease biology — such as subtypes, differences in radio - sensitivities, radio - resistances, local recurrence and in metastatic potential,» explains Bedrosian, the study's senior author.

Most of the research into breast cancer has focused on primary breast cancer, and there is little understanding of the biology underpinning breast cancer that has spread to other parts of the body, known as metastatic cancer.

About 20 percent of breast cancer patients have overexpressed growth receptors, known as Her2 + receptors, on the cancer cells, which cause uncontrolled tumor growth.

For a long time, Daly says she «naively» assumed that, once one family member knew whether or not they carried genes linked to breast and ovarian cancers — known as BRCA1 / 2 — their entire family would understand the result, and what it meant for their own genetic risk.

«Randomized Controlled Pilot Trial of Mindfulness - based Stress Reduction for Breast and Colorectal Cancer Survivors: Effects on Cancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothBreast and Colorectal Cancer Survivors: Effects on Cancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothCancer Survivors: Effects on Cancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothCancer - related Cognitive Impairment,» published online in advance of print in the Journal of Cancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothCancer Survivorship, is the first randomized clinical trial to evaluate the effects of mindfulness - based stress reduction, known as MBSR, on fatigued breast and colorectal cancer survivors, the majority of whom had been treated with chemothbreast and colorectal cancer survivors, the majority of whom had been treated with chemothcancer survivors, the majority of whom had been treated with chemotherapy.

Mutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic testing for familial breast cancer.

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as «estrogen receptor positive» (ER +), including ER + cancers that are resistant to standard treatments.

«We've known for years that prostate cancer is driven by androgens and now it's increasingly clear that androgens and androgen receptors can influence many breast cancers as well.

Radiotherapy to the chest wall and regional lymph nodes (under the arm, above the collar bone and under the breast bone), known as regional nodal irradiation, is used after mastectomy in women with node - positive breast cancer who are treated with adjuvant systemic therapy.

The study, published by the journal Proceedings of the National Academy of Sciences, demonstrates that the Disney lab's compound, known as Targaprimir - 96, triggers breast cancer cells to kill themselves via programmed cell death by precisely targeting a specific RNA that ignites the cancer.

Most cancer is not inherited — though there are well - known mutations that increase susceptibility to cancer, such as BRCA1 and BRCA2, both of which are associated with breast cancer.

Professor Michael Lisanti, from The University of Manchester — part of Manchester Cancer Research Centre, said: «We know that high breast density can greatly increase a woman's breast cancer risk as well as other factors such as aging, family history and presence of mutations in genes such as BRCA 1 and BCancer Research Centre, said: «We know that high breast density can greatly increase a woman's breast cancer risk as well as other factors such as aging, family history and presence of mutations in genes such as BRCA 1 and Bcancer risk as well as other factors such as aging, family history and presence of mutations in genes such as BRCA 1 and BRCA 2.

The screening revealed coibamide A to be capable of killing many types of cancer cells, but Ishmael decided to focus subsequent studies on two types in particular — brain tumors, or glioblastomas, and a breast cancer subtype known as triple negative breast cancer.

Bovine growth hormone is also known to stimulate the production of insulinlike growth factor 1 (IGF1) by the liver; some studies have shown that high levels of IGF1 in the bloodstream may heighten the risk of prostate and breast cancers as well as a woman's chance of conceiving twins.

The team identified an lncRNA known as LINK - A, that activates HIF1 signaling in triple - negative breast cancer.

Though unproven and hotly debated, the theory remains intriguing because known cancer - causing genes such as BRCA - 1 explain only a percentage of human breast cancer cases, and because viruses do cause other forms of cancer in humans and animals.

The mechanism is known as NMD (nonsense - mediated mRNA decay), and scientists found that exposing breast cancer cells to a molecule that inhibits NMD prior to treatment with doxorubicin, a drug used to treat leukemia, breast, bone, lung and other cancers, hastens cell death.

At this year's San Antonio Breast Cancer Symposium, UNC Lineberger researchers and collaborators shared the outcomes of their investigation into the incidence of brain metastasis after a series of drugs were approved to treat HER2 - positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States inBreast Cancer Symposium, UNC Lineberger researchers and collaborators shared the outcomes of their investigation into the incidence of brain metastasis after a series of drugs were approved to treat HER2 - positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States inCancer Symposium, UNC Lineberger researchers and collaborators shared the outcomes of their investigation into the incidence of brain metastasis after a series of drugs were approved to treat HER2 - positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States inbreast cancer, starting with trastuzumab, also known as Herceptin, in the United States incancer, starting with trastuzumab, also known as Herceptin, in the United States in 1998.

UNC Lineberger researchers reported at the San Antonio Breast Cancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2 - positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemothBreast Cancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2 - positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemothCancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2 - positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemothbreast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemothcancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemotherapy.

While AIs significantly reduce the risk of breast cancer recurrence, they often lead to bone loss or severe joint pain, known as arthralgia.

A grassroots network of women known as the National Breast Cancer Coalition was the driving force behind lobbying for the $ 210 million allocated to breast cBreast Cancer Coalition was the driving force behind lobbying for the $ 210 million allocated to breast cCancer Coalition was the driving force behind lobbying for the $ 210 million allocated to breast cbreast cancercancer.

These mutations are known for being strong indicators of breast and ovarian cancer risk, as well as other types of cancer.

The «hotspots» of these trans associations, when grouped by pathway, highlight known targets of dysregulation in breast cancer such as ERBB2 and MYC.

«Komen has set a Bold Goal, but we know we will not be able to achieve this alone — only as a community, which is why our partnership with the Milburn Foundation and the Inflammatory Breast Cancer Research Foundation is so valuable.»

«We speak to many people who are concerned about breast cancer through our 24/7 YourShoes Breast Cancer Support Center,» said Margaret C. Kirk, CEO, Breast Cancer Network of Strength (formerly known as YME National Breast Cancer Organizabreast cancer through our 24/7 YourShoes Breast Cancer Support Center,» said Margaret C. Kirk, CEO, Breast Cancer Network of Strength (formerly known as YME National Breast Cancer Organizacancer through our 24/7 YourShoes Breast Cancer Support Center,» said Margaret C. Kirk, CEO, Breast Cancer Network of Strength (formerly known as YME National Breast Cancer OrganizaBreast Cancer Support Center,» said Margaret C. Kirk, CEO, Breast Cancer Network of Strength (formerly known as YME National Breast Cancer OrganizaCancer Support Center,» said Margaret C. Kirk, CEO, Breast Cancer Network of Strength (formerly known as YME National Breast Cancer OrganizaBreast Cancer Network of Strength (formerly known as YME National Breast Cancer OrganizaCancer Network of Strength (formerly known as YME National Breast Cancer OrganizaBreast Cancer OrganizaCancer Organization).